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Human immunoglobulin G4 (hIgG4) is increasingly being used for the detection of various infectious 
diseases and in allergy-related immunoassays, thus, anti-hIgG4 antibody is of interest in the 
development of diagnostic tests. The present study was conducted to produce a recombinant peptide 
antigen that can be used to generate monoclonal antibodies specific to hIgG4. The cDNA coding for the 
hinge region of hIgG4 was derived from mRNA from a human blood sample using reverse transcription 
polymerase chain reaction (RT-PCR). The cDNA was verified by sequencing and cloned into pQE-2 
expression vector to construct pQE-2-IgG4. The latter was transformed Escherichia coli M15 cells, 
recombinant protein expression induced by IPTG and the expression was confirmed by SDS-PAGE and 
western blot analysis. 
 





In recent years, there is an increasing use of human IgG4 
(hIgG4) in diagnostics, such as for use in the detection of 
helminthic diseases (Anantaphruti et al., 2005). Towards 
this aim, the present study was conducted in an attempt 
to produce recombinant hIgG4 peptide. 
Basic diagnostic tests, such as indirect hemag-
glutination, indirect immunofluorescence (IIF), radio-
immunoassay and enzyme linked immunosorbent assay 
(ELISA), with relatively crude antigens were reported to 
be employed to detect infection status in human beings 
(Jacobson, 1996). Recent advances in immunochemistry 
and molecular biology have resulted in development of 
assays with markedly improved sensitivity and specificity. 
However, most of the methods remain high cost and 
not readily available in many less developed countries 
where most parasitic diseases are found. It is therefore of 
great importance that approaches being taken to develop 
techniques of disease detection would combine the 
properties of user-friendly, easy accessibility and low cost 
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and sensitivity of the detection. The use of hIgG4 as a 
marker of active helminthic infections could fulfill these 
requirements and the use has been widely documented. 
This includes reports on lymphatic filariasis, oncho-
cerciasis, strongloidiasis, schistosomiasis, hydatid 
diseases, cyctercercosis and angiostrongyliasis (Rahmah 
et al., 2001). 
Native proteins have traditionally been used to raise 
monoclonal antibodies and for some applications; there 
are advantages in using antibodies against native 
proteins. However, there are also distinct advantages of 
using peptides over native proteins, such as reduction of 
potential cross-reactivity between structurally homo-
logous proteins, production of different antibodies for 
different epitopes of the same protein and production of 
antibodies for proteins with post-translational modifi-
cations (Geysen, 1985). Thus, peptides are now 
becoming more commonly used in antibody production. 
The hinge region of the hIgG4 was targeted for the 
peptide production since this region contains peptide 
sequences specific to hIgG4 (Lu et al., 2007). Thus, the 
use of this peptide as antigen for anti-hIgG4 monoclonal 
antibody (MAb) production would be expected to increase 
the specificity of the antibody. This in turn may increase 








MATERIALS AND METHODS 
 
Bacteria strains and medium 
 
Escherichia coli Top10 was used for transformation of pGEM-T-
IgG4 plasmid construct, whereas, E. coli M15 was used as a host 
for the expression of pQE-2-IgG4. Both bacterial strains were 
obtained from Qiagen, Germany. Luria-bertani (LB) containing 100 
µg/ml ampicilin was used as the culture medium.  E. coli M15 strain 
contains both the expression (pQE) and the repressor (pREP4) 
plasmids and can be used for the production of recombinant 
proteins. It was  derived from E. coli K12 and have the phenotype 
























Plasmid vectors pGEM-T and pQE-2 were purchased from Qiagen, 
Germany. PQE-2 is used for the expression of N-terminally His-
Tagged protein in E. coli and is based on the T5 promoter 
transcription-translation system.  
 
 
Isolation of total RNA 
 
The total RNA was isolated from fresh human blood using Tri-
reagent (Fermentas, USA) according to the manufacturer’s 
recommendations. The quantity and quality of RNA were analyzed 
by denaturing agarose gel electrophoresis, then, stored at -80°C. 
Informed consent was obtained before the human blood sampling 
by venepuncture, as required by USM human ethics committee. 
 
 
Reverse transcription polymerase chain reaction (RT-PCR) 
 
Reverse transcription was performed using a commercial kit 
(Fermentas, USA)  1 µg of the total RNA from the human blood was 
converted to single stranded cDNA using first strand cDNA- 
synthesis kit. Two-microlite of the product was used as a template 
to amplify human IgG4 hinge region of the cDNA sequence for 35 
cycles. 1 µl of total RNA was added into 1 µl of oligo (dt) primer and 
the total volume was added to 12 µl with the addition of DEPC 
treated water. The mixture was incubated at 70°C for 5 min. 4 µl of 
5 x reaction buffers, 1 µl of Ribolock Ribonuclease inhibitor and 2 µl 
of 10 mM dNTP were added into the tube. The tube was incubated 
at 37°C for 5 min followed by the addition of RevertAid M-Mulv 
reverse transcriptase to a final volume of 20 µl. The mixture was 
then, incubated at 42°C for 60 min. The reaction was stopped by 
heating at 70°C for 10 min and chilled on ice. The PCR was 
performed using the following conditions: Initial denaturation: 94°C 
for 5 min; denaturation: 94°C for 45 s; annealing: 65°C for 1 min; 
elongation: 72°C for 45 s; final hold: 72°C for 10 min. 
After the last cycle of amplification, 10 µl of product was stained 
with ethidium bromide, analyzed by agarose gel electrophoresis 





The hinge region of hIgG4 consists of 20 amino acids. Among 
them, 14 were identified to be distinctive to hIgG4 (Tan et al., 
1990). The human specific amino acid sequence was reported to 
be SYGPPSAPEFLGGP (Lu et al., 2007). Primers were designed to  




amplify the region around this hinge region. In addition, the primer 
design ensured that the amplification product would be flanked by 
5’NdeI and 3’ Not1 restriction endonuclease cleavage sites to 
facilitate directional cloning into plasmid pQE-2 vector. 
The sequences of primers were as follows: Forward primer 3: 5'-




Cloning of PCR products 
 
The human IgG4 cDNA was then used as a template for PCR 
cloning. PCR cycle comprised 30 cycles of heating at 94°C for 1 
min, annealing at 62.5°C for 1 min and extension at 72°C for 2 min. 
The PCR product of approximately 218 bp product was then, 
cloned into the Not1 and Nde1 sites of pGEM-T cloning vector 
(Promega) to yield pGEM-T-IgG4 and subsequently transformed 
into Top10 E. coli. Blue-white colony screening on ampicillin plate 
was used to select positive clones. Plasmid from positive clones 
was extracted using plasmid purification kit (Promega, USA) and 
confirmed by Nde1 and Not1 restriction endonuclease digestions 
before sending for sequencing.  
 
 
Recombinant sequence construction 
 
Construction procedure is shown in Figure 1. The pGEM-T-IgG4 
was subjected to digestion with Nde1 and Not1 restriction 
endonucleases, followed by gel purification of the 218 bp desired 
cassette. The pQE-2 vector was similarly digested with Nde1 and 
Not1 restriction endonucleases and gel purified. The insert cassette 
with the size of 218 bp was ligated to the linearized pQE-2 vector 
with T4 ligase in the presence of the desired buffer. The mixture 
was incubated at 37°C for 1 h. This yielded pQE-2-IgG4 with His-
tag. The resulting construct was then transformed into TOP10 E. 
coli cells and the positive clones were screened by blue white 
colony screening on ampicillin plate, followed by analysis by Nde1 
and Not1 restriction endonuclease digestions. 
 
 
Expression of recombinant protein in M15 cells  
 
The His-tagged pQE-2-IgG4 was transformed into E. coli M15 
expression host. The transformants were cultured on the plates 
containing kanamycin (25 µg/ml) and ampicillin (100 µg/ml). Two 
isolated colonies were then, cultured in 1000 ml LB medium and 
induced for the protein expression with 1 mM IPTG and incubated 
for 4 h. A volume of 1 ml culture was collected at time zero (before 
IPTG induction) and the rest collected at the end of the incubation.  
The bacterial cells were spun down and the supernatant 
discarded. Half of the pellet was lysed in lysis buffer containing 
lysozyme; another half of the pellet was lysed in lysis buffer without 
lysozyme. For sample obtained before IPTG induction, only 
lysozyme-treated pellet was used. Lysates were incubated on ice 
for 30 min, followed by cell-breakage using French press and then 
centrifuged. Thereafter, both supernatant and pellet processed with 
and without lysozyme were analyzed using SDS-PAGE.   
 
 
SDS-PAGE and western blot analysis of recombinant hIgG4 
hinge region peptide  
 
The samples was added to the SDS sample buffer, heated at 95°C 
for 5 min and analyzed on a 12% SDS-PAGE. The electrophoresed 
recombinant peptide was transferred onto nitrocellulose membrane 
using mini trans-blot apparatus (Bio-Rad, USA) according to the 
manufacturer’s recommendations. The blotted membrane was 
blocked with  casein  (20%)  for  1 h,  washed  five  times  with  Tris-  












Figure 2. Total RNA isolated from human 
blood sample was subjected to agarose gel 
electrophoresis. The bands of 28s and 18s 
rRNA could be clearly observed. 
buffered saline with 0.05% of Tween-20 (TBST), incubated with 
anti-His-HRP antibody (1:1000 in PBS pH 7.3, Santa Cruz, USA) 
for1 h at room temperature then washed three times with TBS-T. 
Binding of the antibody to the antigen was detected using 
supersignal west Pico chemiluminescent substrate (Thermo 






RNA isolation and RT-PCR 
 
Figure 2 shows the gel electrophoresis picture of the total 
RNA isolated from human blood sample, clear bands of 
28s and 18s rRNA can be observed. The result also 
showed that, there was no obvious degradation of the 
isolated RNA that was used in the reverse transcription to 
cDNA. RT-PCR reaction mix was analyzed using a 1% 
agarose gel electrophoresis. A specific band with the 
approximate expected size of amplicon of interest (218 
bp) was shown in the gel (Figure 3). The sequence of the 
end product, pGEM-T-IgG4 was as expected with no 











Figure 3. Product of the RT-PCR reaction ran on a 1% 








Figure 4. Plasmid DNA isolated from E. coli M15 transformed with 
pQE-2-IgG4 was digested with restriction endonucleases Not1 and 
Nde1. Agarose gel electrophoresis result showed the band of pQE-




Based on the earlier mentioned, the corresponding 
peptide comprised 68 residues of the expected sequence 
of amino acids. 




Construction of pQE-2-IgG4 expression plasmid DNA 
 
Figure 4 shows the gel picture of the result of restriction 
digestion of pQE-2-IgG4. Two bands representing the 
vector pQE-2 (4.8 kb) and the insert (218 bp) in each 
lane of DNA extracted from clones 1, 2 and 3 can be 
seen. The digestion was not complete and hence, the 
undigested DNA construct could be observed at the top 
of each lane. These pQE-2-IgG4 constructs were sent for 
sequencing and the results reconfirmed that, the correct 
sequence has been inserted (data not shown). 
 
 
Recombinant peptide expression of hIgG4 hinge 
region  
 
The expected size of the expressed protein was appro-
ximately 12 kDa. As shown in Figure 5, there is a little 





 lanes). With IPTG induction, the amount of 
recombinant protein obtained was much higher. The use 
of lysozyme results in higher amounts of the recombinant 
protein than without the use of the enzyme (lanes 5 and 
3, respectively). As the protein of interest was tagged 
with six histidines at the N-terminal, the presence 
recombinant protein in the samples was confirmed by 
western blot analysis (WBA) using anti-His-tag-HRP 
(Figure 6). Similar to that seen in SDS-PAGE, under non-
induced condition there was some leaky protein 
expression as shown in lane 1. However, the signal 
detected was relatively low compared with that seen in 
lane 3 from supernatant of cell pellet lysate from IPTG 





The results of the present study confirmed the expression 
of the desired recombinant His-tagged peptide hinge 
region specific to hIgG4. With this peptide, the 
immunization of mice to produce specific anti-hIgG4 MAb 
can be performed. However, the removal of histidine tag 
would first be required to eliminate the production of 
antibody against the His-tag.   
The capability to produce this hIgG4 specific peptide in 
unlimited amounts in the laboratory will be very useful in 
the MAb production and for use in other applications.  
MAb produced against human IgG4 antibody is useful for 
the development of immunoassays to detect helminthes 
infections for use in in-house assays and for diagnostic 
kit production. An example of a detection kit that uses 
anti-human IgG4 is Brugia Rapid
TM
, which is based on 
the principle of binding of the BmR1 recombinant antigen 
to a filarial-specific human IgG4 antibody in patient 
sample, followed by binding of the complex to mouse 
anti-human IgG4 MAb (Rahmah et al., 2001). In the 
process  of  the  diagnostic  kit  production,  a  major  cost  







Figure 5. Equal amounts of proteins from supernatant (medium) and cell pellet lysate were subject to SDS-









Figure 6. Western blot analysis using HRP-conjugated anti-His 
antibody. A thick band at ~12 kDa is seen in the lane from the 




incurred is the purchase of anti-human IgG4. Since this 
kit is for detection of brugian filariasis, a neglected 
tropical disease endemic in poor countries, the ability to 
produce IgG4 MAb would enable the kit to be available at 
a much lower price. Specific IgG4 antibody has also been 
used as a marker of antigen exposure in allergy, 
including those caused by food allergy (Tomee et al., 
1996; Homburger et al., 1986). The levels of specific 
IgG4 antibodies have been measured in clinical studies 
of allergic diseases such as asthma, rhinitis, urticaria, 
aspergillosis (Till et al., 004). In addition, allergen-specific 
IgG4 have also been used in monitoring immunotherapy 
(Aalberse et al., 1993). 
MAbs raised against Fab and Fc regions of the 
antibody has been previously reported, such as for 
cancer research (Li et al., 1998). However, to the best of 
our knowledge, there is no report this far on MAb against 
the antibody hinge region. The peptide of the hinge 
region is the most specific region for IgG4 molecules, 
thus, this was cloned in for future use to produce anti-
human IgG4 MAb. Antibody raised against this region 
would be expected to be more specific than that raised 
against the whole antibody.  
Although, the primary sequence of the peptide 
corresponded to the specific hinge region of hIgG4, the 
folding of the peptide may not mimic the one in the whole 
hIgG4 molecule and hence, the antibody produced from 
the peptide may not be able to recognize the native 
hIgG4. This can only be ascertained after the MAb to the 
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